Skip to content
Company
About
Careers
Clinical
Bullsai Enhance
Bullsai Identify
Bullsai Confirm
Research
FIRMM
FIRMM-PIX
Media
News/Events
Publications
Contact Us
Company
About
Careers
Clinical
Bullsai Enhance
Bullsai Identify
Bullsai Confirm
Research
FIRMM
FIRMM-PIX
Media
News/Events
Publications
Contact Us
Resources
News & Events
September 5, 2024
Turing Medical’s Bullsai Identify Secures FDA Clearance: Ushering in A New Era of Precision Brain Mapping for Neuromodulation Therapy
“Bullsai Identify’s personalized approach to brain mapping takes into account each patient’s unique brain structure and connectivity, offering the potential for better-targeted, more effective treatments, This can lead to more accurate therapies, […]
Read the Press Release
August 14, 2024
Turing Co-Founders Research on Psilocybin and Brain Plasticity Featured in Nature
Psilocybin generates psychedelic experience by disrupting brain network Study advances efforts to harness drug’s mind-altering power to treat mental illness Tamara Schneider-Washington University in St. Louis People who consume psilocybin-containing mushrooms — […]
Read the Press Release
June 3, 2024
Turing Medical Launches New Brain Mapping and Targeting Solution at ASSFN Biannual Meeting
Bullsai precision targeting for personalized neuromodulation therapy NASHVILLE, TENN., JUNE 1, 2024—Turing Medical, the leader in precision targeting for neuromodulation therapies, today announced the launch of Bullsai, its new brain mapping and […]
Read the Press Release
March 17, 2022
Turing Medical Co-Founders Publish in Nature
Turing Medical (Turing), formerly Nous Imaging, is proud to share that research led by our co-founders, Nico Dosenbach, M.D., PhD and Damien Fair, PA-C, PhD has been published on March 16 in Nature.
Read the Article
February 10, 2021
Turing Medical Co-Founder Damien Fair Awarded MacArthur Fellowship
Fair among 21 winners of prestigious “Genius Grant”
Read the Press Release
1
2
3
Next